Search
About
Our Story
Who We Are
Leadership Team
Board of Directors
Pipeline
Overview
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
Search for:
News & Events
About
Our Story
Who We Are
Leadership Team
Board of Directors
Pipeline
Overview
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
Upcoming Events
There are no upcoming events at this time
Recent Press Releases
Apr 15, 2024
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Jan 25, 2024
Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
Recent Media
May 6, 2019
Organovo: Bioprinting Could be the New Solution to Organ Transplantation
Oct 19, 2018
3D Method Uses Patients' Own Cells to Repair Tissue Damage
About
Our Story
Who We Are
Leadership Team
Board of Directors
Pipeline
Overview
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact